Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
France imposes curfews in parts of Paris, other cities after weekend of riots
Residents trapped as torrential rain floods towns in eastern Spain
Zelenskyy says Ukraine got no warning as Russia launches major attack
World Food Programme cuts aid to 500,000 Palestinians in Gaza, cites funding shortages
Bomb threat forces Austrian Tel Aviv-Vienna flight to land in Bulgaria
